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Article 
SPECIAL ISSUE ON PEER-TO-PEER AND USER-LED SCIENCE 
The public production and sharing of medical 
information. An Australian perspective  
Henry C.H. Ko  
ABSTRACT: There is a wealth of medical information now available to the public through various 
sources that are not necessarily controlled by medical or healthcare professionals. In Australia 
there has been a strong movement in the health consumer arena of consumer-led sharing and 
production  of  medical  information  and  in  healthcare  decision-making.  This  has  led  to 
empowerment of the public as well as increased knowledge-sharing. There are some successful 
initiatives and strategies on consumer- and public-led sharing of medical information, including 
the formation of specialised consumer groups, independent medical information organisations, 
consumer peer tutoring, and email lists and consumer networking events. With well-organised 
public  initiatives  and  networks,  there  tends  to  be  fairly  balanced  information  being  shared. 
However, there needs to be caution about the use of publicly available scientific information to 
further the agenda of special-interest groups and lobbying groups to advance often biased and 
unproven opinions or for scaremongering. With the adoption of more accountability of medical 
research, and the increased public scrutiny of private and public research, the validity and quality 
of medical information reaching the public is achieving higher standards. 
Background 
Sources of medical information 
Medical  information  now  available  to  the  public  through  various  sources  that  are  not  necessarily 
controlled by medical or healthcare professionals. This can be through the internet, non-governmental 
organisations, independent consumer organisations, and commercial sources. In Australia there has been 
an  increase  in  user-led  health  and  bioscience  communication.  In  particular,  there  has  been  a  strong 
movement in the health consumer arena of consumer-led sharing and production of medical information 
and in healthcare decision-making. This has led to empowerment of the public as well as increased 
knowledge-sharing.
1,2 
Traditional  sources  of  medical  knowledge  have  been  through  the  expert-to-patient  model,  with  the 
public  tending  to  defer  any  decisions  about  medical  issues  to  the  medical  experts  at  the  top  of  the 
“knowledge hierarchy”.
3,4 This relied heavily on personal face-to-face contact with experts or visiting 
medical libraries to find research publications done by scientists, medical researchers and clinicians. 
However, with the increasing use of the internet as a source of information that is accessible to more and 
more people we have seen a flattening of the world.
5 Combining the converging factors of increasingly 
busy healthcare professionals (clinicians, pharmacists, etc), the increasing free availability of health and 
medical information online (though NLM Medline,
6 PloS,
7 and various free-access online journals and 
databases), the increasing thirst for knowledge of consumers and the public, we see the elements that 
have contributed to the user-led or consumer-led production and sharing of medical information. 
In the author's opinion the open-access revolution and the embracing of this concept by the biomedical 
and  healthcare  research  disciplines  globally  have  made  the  creation  of  consumer-led  production  and 
sharing  of  medical  information  easier.  This  also  points  to  the  democratisation  of  information  and H.C.H. Ko  2 
 
elements of 'freedom of information'. The spread of user- or consumer-controlled medical information 
and content contributes to the strengthening of the information economy and democracy.
8-10 The fact that 
consumers have relatively free access to information and knowledge created by society, and can engage 
with the parties that create the knowledge, is also a mark of democracy.
8-10 Whether the sources are 
accurate and reliable and if consumer interpretations of the information are valid are entirely different 
questions that warrant further investigation.
11-14 
User-led medical and bioscience communication in Australia 
This article reviews some of the successful initiatives and strategies on consumer- and public-led sharing of 
medical  information  in  Australia,  including  the  formation  of  specialised  consumer  groups  that  discuss 
medical information and policy, independent medical information organisations, consumer peer tutoring on 
medical issues, and email lists and consumer networking events. A feature of many of these strategies are 
that many of the participants are not medical or healthcare professionals yet are able to discuss in depth 
various medical and policy issues. Those of the public who are involved in medical issues communication 
are very adept in conceptualising and explaining the content and issues in their medical interest area. This in 
part stems from the high quality and “digestibility” of the information reaching the public that is shared 
between users, as well as the support structures and often personal motivations of the users that are involved 
in sharing the information. Figure 1 shows a simple representation of the inter-relationship between the 
various players who contribute to the user-led production and sharing of medical information. 
 
 
 
 
Figure 1. The inter-relationship of the various players in user-led production and sharing of medical information. All elements 
interact with each other continuously and contribute to the user-led production and sharing of medical information. 3  The public production and sharing of medical information. An Australian perspective 
   
 
This article is not focussing on the well developed field of health promotion, which is usually a top-
down approach of experts or policy-makers teaching the public consumers, but on how technical medical 
and  bioscience  information  is  transferred  within  the  public  by  consumers.  Sometimes  the  medical 
information  can  be  transferred  in  the  other  direction  from  the  public/consumers  to  the  experts  –  a 
“bottom-upwards”  approach  if  you  will.  The  workings  of  clusters  of  public  and  consumer-led 
communication based around specific interest groups (eg cancer) will also be discussed, as well as a 
discussion  on  some  of  the  benefits  and  potential  dangers  of  user-led  science  communication  in  the 
medical  and  bioscience  arena.  Something  that  many  researchers  in  medical  and  health  consumer 
engagement mention is that there is a lack of published literature on how user and consumers are using 
medical information.
15 The recording, evaluation and publishing of the consumer engagement process 
and  consumer-led  medical  communication  is  not  systematically  nor  consistently  done.  Most  of  the 
information  in  this  area  is  from  knowledge  of  local  initiatives  or  word  of  mouth.  Many  of  the 
observations and reflective analysis presented here are from my own involvement in health and medical 
consumer groups. In this article I use the terms bioscience, medical and bioscientific interchangeably, but 
they are similar in meaning. 
Enablers of user-led medical and bioscience communication in Australia 
Healthcare consumer groups 
With an increasing awareness of the healthcare system and in many cases a very personal interest in a 
specific disease or health condition, healthcare consumers are an excellent example of user-led science 
communication. In the author's own experience, healthcare consumers are articulate and knowledgeable 
about  medical  issues  and  policies.  The  community  building  of  healthcare  consumer  groups  helps  to 
consolidate the medical and bioscience knowledge that the consumers have, but also help to increase their 
power in sharing this information to other new consumers and users (eg patients). In a bottom-up approach 
to information sharing, healthcare consumer groups can also influence and guide health and medical policy 
by advising governments and healthcare organisations in policy forums such as the National Medicines 
Symposium
16 on the “Quality use of medicines” which was held in Canberra, Australia, in May 2008, the 
Second Joint Medicines Policy Conference
17 which was held in Canberra, Australia, in November 2008, and 
consumer consultations with the Australian Commission on Quality and Safety in Healthcare.
18,19 This is a 
unique  position  where  we  have  the  users  and  consumers  of  information  influencing  the  top  of  the 
knowledge and organisational power hierarchy. Of course, there is variation in how public engagement in 
science is done and to what extent it can influence decision-making processes.
20 
Examples of health consumer groups in Australia consisting of users and consumers of health and medical 
information that are producing and sharing medical information include the Consumers Health Forum of 
Australia,
21 Cancer Voices Australia
22 and its state counterparts, and Health Consumer Councils.
23 Smaller 
examples of user and consumer groups may be community support groups for specific illnesses where 
medical information is shared between a small number of people (eg arthritis support groups for the elderly 
in nursing homes). Table 1 lists some Australian healthcare consumer groups. 
The  success  of  health  consumer  groups  for  being  user-led  medical  and  bioscience  communication 
organisations in Australia lies in the involved individuals' intrinsic and high level of personal affinity to 
the organisation's causes. This is usually due to the disease or medical condition the healthcare consumer 
group or organisation represents. The success of healthcare consumer groups in creating an environment 
for  user-led  medical  and  bioscience  communication  may  be  harder  to  replicate  in  other  scientific 
disciplines. Fields such as physics, although affecting us every moment of our lives, does not seem to 
elicit  as  high  an  immediate  emotional  or  personal  bond  as  a  health  conditions  do.  With  biomedical 
information there is an intrinsic bond and utility to that information that is tied up to our identities.
24 With 
an  increasingly  “biomedicalised  society”  we  can  only  assume  an  increasing  trend  for  biomedical 
technologies, for better or for worse, to define who we are, at least physiologically and anatomically.
24 In 
environmental areas, at the public interest level, there are various organisations that are driven by users 
and consumers, such as bird-watching clubs (in the biology and ecology fields), gemstone collectors (in 
the geology field) to collectives of users in more applied activities such as clubs catering for robotics and 
electronics enthusiasts (in the engineering and electronics fields). One factor that is prominent in the H.C.H. Ko  4 
 
 
 
Alzheimers Australia Incorporated. URL: www.alzheimers.org.au 
Arthritis Australia and affiliated state-based arthritis organisations. URL: www.arthritisaustralia.com.au/ 
Asthma Foundation Australia. URL: www.asthmaaustralia.org.au 
Australian Crohns and Colitis Association. URL: www.acca.net.au 
Australian Federation of AIDS Organisations. URL: www.afao.org.au 
Breast Cancer Action Group Inc. URL: www.bcag.org.au 
Cancer Voices Australia and affiliated state-based cancer organisations. URL: 
www.cancervoicesaustralia.org.au 
COTA Over 50s Ltd. URL: www.cotaover50s.org.au/ 
Federation of Ethnic Communities' Councils of Australia Inc. URL: www.fecca.org.au/ 
Health Consumers' Council WA (Inc). URL: www.hconc.org.au 
ME/Chronic Fatigue Syndrome Association of Australia and affiliated state-based organisations. URL: 
www.mecfs.org.au/ 
National Association of People Living with HIV/AIDS, Australia (NAPWA). URL: www.napwa.org.au 
Parkinson's Australia Inc and affiliated state-based organisations. URL: www.parkinsons.org.au 
Table 1. A list of some Australian healthcare consumer groups and their websites. 
success of healthcare consumer organisations is the relatively high profile, continuous high levels of 
public  and  governmental  support,  and  in  some  cases  some  commercial  support  afforded  to  these 
consumer organisations to enable the sustainability of their activities that does not seem to be afforded to 
other types of scientific user and consumer groups. For example, health supplement manufacturers and 
sporting  organisations  have  given  financial  and  media  support  over  the  years  to  cancer  research 
campaigns, especially for breast cancer, in Australia. 
Independent medical information organisations 
Organisations such as the National Prescribing Service,
25 the Health Issues Centre,
26 and the Cancer 
Council Australia
27 and its state counterparts, provide independent medical information to consumers and 
users of medicines. They are usually staffed by biomedical scientists and healthcare professionals. What 
organisations such as these do for the user-led production and sharing of scientific information is produce 
and disseminate information to the general public. While these organisations are not public “users” or 
“consumers”, they provide an important source of reliable and understandable information for users and 
consumers, which in turn help to perpetuate a more knowledgeable public. 
The role of the independent medical information organisation to the phenomenon of user-led production 
and sharing of medical information is partly as an information provider and partly as a facilitator of user 
communication. With the provision of appropriately targeted medical information to users and consumers 
we have seen empowerment of consumers and users to share and create knowledge networks of healthcare 
and  medicine  consumers.  The  empowerment  of  consumers  in  accessing  understandable  biomedical 
information makes consumers more confident about the medical field and can empower them to pursue 
further reading or research in the medical literature. An example of the medical information organisation 
improving the reach of medical information to diverse communities is the partnership between the National 
Prescribing Service and FECCA to provide translations of medical information for consumers in Australia 
in their “multicultural community quality use of medicines program”.
28 An interesting relationship between 
consumers and some of these medical information organisations is that consumers can also contribute to the 
policies, strategies, and advocacy activities of these organisations. There is a symbiotic relationship where 
communication of medical information is occurring back and forth between these groups. 
Various  avenues  of  popular  media,  which  may  be  considered  somewhat  as  independent  medical 
information organisations, also feed consumers and users of medical information. On television (e.g. 
Discovery Health), websites (e.g. HealthInsite,
29 which is an Australian Government initiative to provide 
health  and  medical  information  to  the  public),  in  magazines  (e.g.  Men's  Health),  and  other  media 
channels are easily accessible sources of information. Popular science publications that cater for more 
discerning  users  such  as  New  Scientist,  Australia’s  Cosmos  Magazine,
30  and  Australasian  Science
31 
regularly run articles on various scientific areas, including medical or health breakthroughs. 5  The public production and sharing of medical information. An Australian perspective 
   
 
Consumer peer tutoring programmes 
With the increasing empowerment of healthcare consumers and users of medical services and products in 
Australia, there has also been the creation of consumer peer tutoring programmes. These are programmes 
where users of medicines tutor other new or less experienced users about how to use their medicines and 
about healthcare issues in general, and there are similar activities in other settings.
32-35 In Australia there are 
a few reasons for these peer tutoring programmes coming into existence. One reason is due to the relatively 
low access to healthcare professionals due to living in rural areas where access to doctors or pharmacists is 
low, or living in areas with a low doctor-to-population ratio or low pharmacist-to-population ratio. These 
may be reasons for minimal opportunity for the users and consumers to get to know their new medicines or 
medical routines. Other reasons are that consumers may simply not understand the medical information 
even after speaking to a healthcare professional. Things like inadequate cultural and linguistic translations 
may  prevent  the  proper  dissemination  of  the  relevant  medical  information  to  a  consumer  from  a 
multicultural background, and this is something that organisations such as the NPS and FECCA mentioned 
previously are collaborating on to overcome.
28 In Australia, more experienced users and consumers have 
seen this gap in the healthcare journey and acted to help newer consumers. Examples of peer tutoring do 
occur in Australia but are not recorded in the published science communication literature to this author’s 
knowledge. There are some institutional reports that elaborate on this and other methods of communication 
though.
36,37 The fact that users and consumers can teach other users and consumers of health and medical 
information is testament to the power and effectiveness of user-led bioscience and medical communication. 
Email lists and online networks 
With an increasingly interconnected world, the use of email and online tools is very useful in sustaining 
the user-led production and sharing of scientific information. The importance of email and online tools to 
the biomedical and healthcare user and consumer is high in large networks of consumers. Examples of 
networks of users and consumers in the medical field include various health consumer organisations such 
as CHF, and the various state-based and national Cancer Voices organisations. The members of these 
lists  discuss  medical  issues  very  competently  and  create  an  environment  where  issues  are  debated. 
Examples of medical and scientific issues recently discussed via online networks include the quality of 
medical evidence, the scientific validity and use of complementary medicines, and the regulations of 
medical technologies within Australia. 
The use of email lists and online networks is something that is common internationally in various medical 
information consumer and user organisations. International examples include the International Alliance of 
Patients’ Organisations
38 which has The Patients’ Exchange Listserv, Consumers Advancing Patient Safety,
39 
and the WHO World Alliance for Patient Safety.
40 The advantage of online networks is the dissemination and 
access to medical information from many more users and consumers around the world, and therefore enriching 
the knowledge of users who are geographically restricted so much more easily. This in some respects is a 
positive effect from what Thomas Friedman suggests as the “flattening of the world”.
5 However, not everyone 
has access to the technologies of the “flat world” yet. The drawback of online tools is that users from remote 
regions as well as elderly users may not have access to these avenues of communication or may not be adept at 
using  these  technologies.  These  are  important  demographics  in  user-led  communication  of  medical 
information because they provide unique views and are usually very knowledgeable about medicines, health 
issues and issues pertaining to effective communication of medical issues. The penetration of the internet in 
Australia is relatively low compared to other OECD countries and is approximately 50% of households for 
rural  and  regional  areas.
41  This  may  be  why  many  communications  from  user-led  health  consumer 
organisations still provide hardcopy communications for their membership – to maximise communication with 
those  not  able  to  access  electronic  communication  tools.  Some  users  may  simply  prefer  hardcopy 
communications. 
The use of email lists and online networks in other fields of user-led science communication is unclear, 
but it is probably the most easily utilised tool for users and consumers of scientific information to use to 
share  ideas  and  information  and  create  networks  of  similar  users.  Blogs  and  online  groups  (e.g. 
Facebook) are other online tools used for creating a virtual community. At present, it is unclear how 
consumers are using these tools to create and share medical information. It is unclear how strong the H.C.H. Ko  6 
 
uptake of the use of these tools is and what impact these tools have on user-led science communication, 
particularly medical and bioscience communication. 
The positives and negatives of user-led medical and bioscience communication 
From the medical and bioscience field, the impact of the information being produced and shared has a 
strong  personal  element  to  it.  Producers  and  consumers  of  the  information  must  be  wary  of 
sensationalisation of this information in the public domain.
13,14,42 With well-organised publicly-funded 
initiatives and networks, there tends to be fairly balanced information being shared. This can be in part 
due  to  the  close  partnership  between  government  policy,  research,  and  medical  institutions  with  the 
public.
4,43-45  There  are  mechanisms  for  incorporating  the  input  of  the  public  into  decision-making.
46 
However, there needs to be caution about the use of publicly available scientific information to further 
the agenda of special-interest and lobbying groups, which could be used to advance potentially biased or 
unproven opinions or for scaremongering, in areas such as GMO, genetic screening, stem cell therapies 
and nanotechnologies.
24,47-49 
Public empowerment in healthcare decision-making 
In the medical and bioscience fields there have been a few situations where there has been legitimate 
public  backlash  and  negative  sentiment,  but  also  cases  where  there  has  been  unjustified  hype  and 
scaremongering, with genetic technologies having received much negative reaction, especially for genetic 
therapies and testing.
13,42,50 There is also observed tension between the knowledge of experts versus that 
of lay people.
10 But this tension and power struggle may be simply due to a lack of communication 
resources and knowledge amongst and between professional and lay people, which results in barriers to 
consumer engagement.
37,51-53 In the area of science communication, it is acknowledged that networking 
and shared learning could reduce these barriers to consumer empowerment and sharing of scientific and 
medical information.
37,51-53 Another example of public empowerment have been the enquiries into the 
nutritional content of fast foods, which has seen fast food outlets reduce the fat and sugar content of 
many of their products, as well as now having to provide healthy alternatives (e.g. McDonalds restaurant 
chains). A bit of sensationalisation and creative license is taken when consumers go to extraordinary 
lengths to prove to other consumers the negative effects of a poor diet as was demonstrated by Morgan 
Spurlock in the 2004 movie Super Size Me. How scientific this human experiment was is debatable, but 
the power of a consumer sharing their experience and knowledge gained from that experience to other 
consumers  is  powerful  and  seemed  to  have  been  a  catalyst  for  change  for  the  menu  at  McDonalds 
restaurants in many countries to healthier items. 
With the public more informed and empowered about scientific issues there has been more debate about 
genetic technologies and about who should decide to use them and how they should be used.
54 Even for 
seemingly  less  effective  technologies  and  therapies,  such  as  complementary  medicines,  we  see  that 
informed public and consumer input into the regulatory processes is seeked.
55 Combining biology, health 
and  medicine,  and  agricultural  sciences,  is  a  strong  and  increasing  user-led  movement  of  organic 
nutrition, further purported by non-scientists and celebrities in the food and nutrition arena such as the 
British  chef  Jamie  Oliver.  What  we  see  in  many  consumers  of  organic  products  and  foods  is  an 
understanding of nutrition, health, and ecology (as well as plant and animal biology in highly educated 
consumers) combined with vast networks of consumers who share information on better nutrition and 
environmental issues that affect their health (e.g. pollution, soil health, conservation issues). 
With the acknowledgement of consumer empowerment in medical and policy issues, and the ability for 
consumers to organise themselves into efficient and powerful advocacy groups, the emphasis has now 
shifted to how and when to engage these users of bioscientific and policy information for the public 
good. There has been consensus, including other fields apart from the medical and healthcare field, that 
consumers need to be engaged early in any consultations and decision-making processes.
49,56,57 7  The public production and sharing of medical information. An Australian perspective 
   
 
Science for the people 
The examples of medical information being absorbed, created, and shared by users and consumers are 
examples of the role that science has for public good. It has been a sentiment that science is created for 
the  public  to  use  and  for  it  to  be  disseminated  for  the  betterment  of  humanity.
46,58-60  The  fact  that 
biomedical information is being utilised by users and the public at various levels highlights the utility of 
scientific information and research and the effectiveness of its integration into people's lives.
1,2,9,36,61,62 
We see the effects on increasing the quality of the collective intelligence of a society when informed 
users and consumers are able to contribute to medical and healthcare debates and policies on various 
levels.
1,2,4,9,35,43,44,52,60,62,63  The  fact  that  in  Australia,  the  use  of  Consumer  Advisory  Committees  in 
hospitals,
64 and of involving consumers in high-level policy-making processes
65 is a positive step in 
medical consumer and user empowerment. The trend of increasingly medically informed citizens means 
that consumers are more able to contribute meaningfully to debates and decision-making.
10,15,36 If nothing 
else, the example of bioscientific information being created and shared by users and consumers proves 
that science is not beyond the grasp of the public, and communicating science is not simply a top-down 
affair (i.e. from experts to the public), but can also be a bottom-up process (i.e. from consumers to 
experts and policy-makers). 
“Bioscientific” prejudice 
However, an insight into the user-led sharing and production of biomedical information can see some 
negative  effects  for  a  “scientific  society”.  Because  in  the  medical  fields  consumers  of  biomedical 
information are usually doing so because they have a personal interest in the particular information we 
see  the  creation  of  special  interest  and  lobby  groups  for  particular  medical  causes.  There  are  senior 
consumers of biomedical information and political issues who act as gatekeepers of the information and 
champions of consumer engagement and share their knowledge with less experienced consumers.
33,37 
This helps to keep the user-led sharing and production of bioscientific information flowing in the public 
sphere. Where there are potentially negative effects of consumer-led control of biomedical information 
and policies is when there is what can only be called “competition” between disease groups and lobbies, 
as well as the fact that consumer groups are usually not like typical members of the public.
10,11,66,67 
Competition between medical consumer groups can occur due to competitive government funding for 
initiatives or research programmes for certain diseases or creating a higher public profile for a disease 
group.  It  almost  seems  as  though  the  bioscientific  information  that  empowered  consumers  about 
themselves and about what was happening in their lives creates a chasm between them and other people 
with different biomedical interests because of political and financial competition based on biomedical 
grounds  (e.g.  cancer  competing  with  HIV/AIDS  groups).  What  hypothetically  happens  is  a  sort  of 
“bioscientific prejudice” against those who do not share the same medical experiences or biomedical 
interests as they do. This in some ways refers to the already noted “biomedicalisation” of society, and 
potentially another classification of people.
24 The danger lies where a disease defines who someone is, 
and  these  consumers  exclude  others  in  their  daily  lives  because  they  don't  share  in  their  similar 
biomedical or disease group interests. 
Abuse of positional power 
There is also another danger in the rise of consumer-created and shared medical information. This relates 
to the rise of consumer experts and the trust given to them because of their knowledge and position in the 
community. As well informed as consumers can be about the medical issues and the science behind them, 
we must remember that knowledge in the hands of anybody can be abused and misused. We must be 
wary  that  we  are  not  transferring  power  from  one  set  of  medical  information  gatekeepers  (e.g.  the 
healthcare  professionals)  to  another  group  (e.g.  the  medical  information  consumers),  and  simply 
perpetuating elite voices in health and medicine.
68 Especially in health lobby groups and interest groups 
there can be an almost unquestioning trust in those consumers who have both the medical knowledge and  
personal  experiences  in  the  healthcare  journey  for  whatever  disease  the  lobby  or  interest  group 
represents. In the public policy arena there is strong persuasive power of both scientific knowledge and H.C.H. Ko  8 
 
the personal passion and experience that these consumers bring with them. The strength of combining 
biased and selective “scientific facts” and a strongly emotional personal story can be powerful political 
tools that could be used for unscrupulous ends.
11 In highly emotionally charged issues, sometimes having 
a neutral scientific voice is called for to minimise sensationalisation and bias. What scientists can bring 
with them is the sometimes forgotten power and law upon which science is based – that of dispassionate 
objectivity, impartiality, and a continuous duty to question what they and everyone else currently knows 
and to adjust their beliefs when new scientific evidence is proven. 
In the author’s view, with the adoption of more accountability to the public of where medical research 
funding goes in Australia, and the increased public scrutiny of private and public research, the validity 
and quality of medical information reaching the public is achieving higher standards. With more users of 
the bioscientific information, and increasing general scientific literacy of the public, we may see higher 
levels of scrutiny with an increasingly educated and science-savvy public. 
Conclusion 
Some strategies employed by individuals, public groups, and consumers discussed here might be useful 
in  other  scientific  fields  for  public  communication  of  science  and  technology.  The  formation  of 
specialised  consumer  groups  that  discuss  medical  and  policy  information,  independent  medical 
information organisations, consumer peer tutoring, and email lists and consumer networking events are 
user-led avenues that can be used to create and share biomedical information and to connect with more 
consumers.  With  an  increasingly  biomedicalised  society  and  educated  public,  consumers  of  medical 
information  are  yielding  more  influence  in  the  way  bioscience  is  disseminated  and  absorbed  by  the 
general public. This user-led bioscience communication phenomenon is increasing the public consumer's 
knowledge of medicine as well as empowering them to take action in many arenas of their own health 
and medical policy. 
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